XZH-5 Inhibits STAT3 Phosphorylation and Enhances the Cytotoxicity of Chemotherapeutic Drugs in Human Breast and Pancreatic Cancer Cells
Aiguo Liu(Tongji Hospital), Jiayuh Lin(Nationwide Children's Hospital)
Cited by 29
Related Papers
CD44 as a tumor biomarker and therapeutic target
|Experimental Hematology and Oncology|2020|405
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
|Cancer Research|2010|233
Stat3 activation in human endometrial and cervical cancers
|British Journal of Cancer|2007|164
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis
|Molecular Cancer|2017|151
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
|British Journal of Cancer|2005|150